Could a Century-Old dysentery drug be repurposed to fight COVID-19?
NCT ID NCT05889793
Summary
This study aimed to see if a low-dose oral form of emetine, a drug once used for amoebic dysentery, could safely help treat symptomatic COVID-19. Adults aged 30+ with recent positive tests and symptoms would take the drug or a placebo for 10 days. The goal was to see if it reduced symptoms and prevented severe outcomes like hospitalization, but the trial was terminated after enrolling only 4 people.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Bharatpur Hospital
Bharatpur, Chitwan, 00000, Nepal
-
Johns Hopkins University, Division of Infectious Diseases
Baltimore, Maryland, 21231, United States
Conditions
Explore the condition pages connected to this study.